319 related articles for article (PubMed ID: 27040848)
1. Geographic variation in the use of adjuvant therapy among elderly patients with resected non-small cell lung cancer.
Schroeder MC; Tien YY; Wright K; Halfdanarson TR; Abu-Hejleh T; Brooks JM
Lung Cancer; 2016 May; 95():28-34. PubMed ID: 27040848
[TBL] [Abstract][Full Text] [Related]
2. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant treatment for elderly patients with early-stage lung cancer treated with limited resection.
Veluswamy RR; Mhango G; Bonomi M; Neugut AI; Hershman DL; Aldridge MD; Wisnivesky JP
Ann Am Thorac Soc; 2013 Dec; 10(6):622-8. PubMed ID: 24024700
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
5. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
[TBL] [Abstract][Full Text] [Related]
6. Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer.
Davidoff AJ; Gardner JF; Seal B; Edelman MJ
J Thorac Oncol; 2011 May; 6(5):934-41. PubMed ID: 21372743
[TBL] [Abstract][Full Text] [Related]
7. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
8. Real-world adjuvant chemotherapy patterns and outcomes among elderly patients with resected early non-small-cell lung cancer in the USA.
Lee JM; Wang R; Johnson A; Ogale S; Kent M; Lee JS
Future Oncol; 2023 Jan; 19(1):37-47. PubMed ID: 36662515
[TBL] [Abstract][Full Text] [Related]
9. Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small-Cell Lung Cancer.
Wang EH; Corso CD; Rutter CE; Park HS; Chen AB; Kim AW; Wilson LD; Decker RH; Yu JB
J Clin Oncol; 2015 Sep; 33(25):2727-34. PubMed ID: 26101240
[TBL] [Abstract][Full Text] [Related]
10. Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysis.
Kim BH; Kim HJ; Wu HG; Kang CH; Kim YT; Lee SH; Kim DW
Clin Lung Cancer; 2014 Sep; 15(5):356-64. PubMed ID: 24996882
[TBL] [Abstract][Full Text] [Related]
11. Treatment Patterns and Health Resource Utilization Among Patients Diagnosed With Early Stage Resected Non-Small Cell Lung Cancer at US Community Oncology Practices.
Buck PO; Saverno KR; Miller PJ; Arondekar B; Walker MS
Clin Lung Cancer; 2015 Nov; 16(6):486-95. PubMed ID: 25681298
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of adjuvant therapy in T4 non-small cell lung cancer: An inverse probability of treatment weighting analysis.
Song YT; Yang SL; Fu Z; Liu XH; Yan SY; Wang ZH; Qin TT; Jiang HW; Jin Y; Yin P
Thorac Cancer; 2019 Mar; 10(3):472-482. PubMed ID: 30628189
[TBL] [Abstract][Full Text] [Related]
13. Differences in initial treatment patterns and outcomes of lung cancer in the elderly.
Smith TJ; Penberthy L; Desch CE; Whittemore M; Newschaffer C; Hillner BE; McClish D; Retchin SM
Lung Cancer; 1995 Dec; 13(3):235-52. PubMed ID: 8719064
[TBL] [Abstract][Full Text] [Related]
14. Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.
Fang P; He W; Gomez DR; Hoffman KE; Smith BD; Giordano SH; Jagsi R; Smith GL
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):748-757. PubMed ID: 28366580
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant Chemotherapy in Resected Stage II Non-small Cell Lung Cancer: Evaluating the Impact of Dose Intensity and Time to Treatment.
Ramsden K; Laskin J; Ho C
Clin Oncol (R Coll Radiol); 2015 Jul; 27(7):394-400. PubMed ID: 25800720
[TBL] [Abstract][Full Text] [Related]
16. Delineating the pattern of treatment for elderly locally advanced NSCLC and predicting outcomes by a validated model: A SEER based analysis.
Guo M; Li B; Yu Y; Wang S; Xu Y; Sun X; Wang L; Yu J
Cancer Med; 2019 May; 8(5):2587-2598. PubMed ID: 30945441
[TBL] [Abstract][Full Text] [Related]
17. Racial Differences in Treatment and Survival among Veterans and Non-Veterans with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations.
Williams CD; Alpert N; Redding TS; Bullard AJ; Flores RM; Kelley MJ; Taioli E
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):112-118. PubMed ID: 31624076
[TBL] [Abstract][Full Text] [Related]
18. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
[TBL] [Abstract][Full Text] [Related]
19. Male patients with resected IIIA-N2 non-small-cell lung cancer may benefit from postoperative radiotherapy: a population-based survival analysis.
Kou P; Wang H; Lin J; Zhang Y; Yu J
Future Oncol; 2018 Oct; 14(23):2371-2381. PubMed ID: 29807451
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer.
Schrag D; Rifas-Shiman S; Saltz L; Bach PB; Begg CB
J Clin Oncol; 2002 Oct; 20(19):3999-4005. PubMed ID: 12351597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
